Literature DB >> 11464085

Pulmonary nocardiosis: clinical experience in ten cases.

B Mari1, C Montón, D Mariscal, M Luján, M Sala, C Domingo.   

Abstract

BACKGROUND: Pulmonary nocardiosis is an infrequent infection whose incidence seems to be increasing due to a higher degree of clinical suspicion and the increasing number of immunosuppressive factors.
OBJECTIVE: To study the predisposing factors, clinical characteristics, diagnostic procedures, treatment and progress of pulmonary nocardiosis (PN).
METHODS: Review of 10 patients (9 male, 1 female, mean age 61) with PN in a 600-bed teaching hospital, diagnosed from 1992 to 1999.
RESULTS: Associated diseases observed were chronic obstructive pulmonary disease (COPD) in 6 patients, human immunodeficiency virus (HIV) infection in 3 and polymyalgia rheumatica in 1. Four patients had received oral corticotherapy for COPD for over a year (mean dose 13 mg/day of prednisone or equivalent). The main reason for consultation was an increase in dyspnea in the patients with COPD (6/6) and fever in those with HIV (3/3). Mean time between onset of symptoms and diagnosis was 5 weeks. In 8 patients, the infection occurred outside the hospital setting. The infection was restricted to the lung in 9/10; in the remaining case, the central nervous system (CNS) and subcutaneous tissue were affected. Lobar or multilobar consolidation was the most frequent radiographic pattern found (6/10). Sputum culture was positive when performed (8 cases). Diagnosis was made or confirmed by bronchoscopy (bronchoaspirate or protected specimen brush) in 5 patients. Germs isolated were: Nocardia asteroides (8/10), Nocardia farcinica (1/10), Nocardia otitidiscaviarum (1/10). Cotrimoxazole was the most used empirical treatment (6/10). Resolution was achieved in 5 cases. Four subjects died: 1 HIV patient with disseminated nocardiosis, and 3 COPD patients, 2 of whom had received long-term corticotherapy. Illness recurred in only 1 case, due to failure to comply with treatment.
CONCLUSIONS: (1) In our geographical setting Nocardia presents as a subacute or chronic pulmonary infection, mainly outside the hospital. (2) It tends to affect only the lung. (3) Diagnosis requires a high clinical suspicion, and can be made on the basis of a sputum culture. (4) Nocardia tends to attack patients with underlying COPD, or immunodepressed patients treated with glucocorticoids, or patients with HIV infection. (5) Mortality is high in both COPD and HIV patients. (6) In our area, cotrimoxazole seems to be the most commonly prescribed treatment. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11464085     DOI: 10.1159/000050531

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  18 in total

Review 1.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

2.  Disseminated nocardiosis caused by Nocardia otitidiscaviarum in an immunocompetent host: A case report and literature review.

Authors:  Yanwen Jiang; Aiben Huang; Qiuhong Fang
Journal:  Exp Ther Med       Date:  2016-09-28       Impact factor: 2.447

3.  Phylogeny of the genus Nocardia based on reassessed 16S rRNA gene sequences reveals underspeciation and division of strains classified as Nocardia asteroides into three established species and two unnamed taxons.

Authors:  Andreas Roth; Sebastian Andrees; Reiner M Kroppenstedt; Dag Harmsen; Harald Mauch
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

4.  Nocardiosis in a kidney-pancreas transplant.

Authors:  I Fontana; G Gasloli; A Magoni Rossi; C Bornacina; F Dodi; M Bertocchi; O Soro; P Diviacco; A De Negri; E Bocci; C Ferrari; A Giannone; Umberto Valente
Journal:  J Transplant       Date:  2010-01-26

5.  Emergence of co-trimoxazole resistant Nocardia brasiliensis causing fatal pneumonia.

Authors:  Vineeta Khare; Prashant Gupta; D Himanshu; Deepak Kumar
Journal:  BMJ Case Rep       Date:  2013-04-17

6.  Secular trends of nocardia infection over 15 years in a tertiary care hospital.

Authors:  R Matulionyte; P Rohner; I Uçkay; D Lew; J Garbino
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  Nocardia infection in lung transplant recipients.

Authors:  Babar A Khan; Michael Duncan; John Reynolds; David S Wilkes
Journal:  Clin Transplant       Date:  2008-04-23       Impact factor: 2.863

8.  Frequent exacerbation of pulmonary nocardiosis during maintenance antibiotic therapies in a hematopoietic stem cell transplant recipient.

Authors:  Kazuhiko Kakihana; Kazuteru Ohashi; Mari Iguchi; Kumiko Negishi; Tomokazu Suzuki; Minori Shitara; Misao Honma; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

9.  Nocardiosis in a tertiary care hospital in saudi arabia.

Authors:  Hamdan Al-Jahdali; Salem Baharoon; Salwa Alothman; Ziad Memish; Abdelkarim Waness
Journal:  J Glob Infect Dis       Date:  2011-04

10.  Fatal Nocardia farcinica Bacteremia Diagnosed by Matrix-Assisted Laser Desorption-Ionization Time of Flight Mass Spectrometry in a Patient with Myelodysplastic Syndrome Treated with Corticosteroids.

Authors:  Christian Leli; Amedeo Moretti; Francesco Guercini; Angela Cardaccia; Leone Furbetta; Giancarlo Agnelli; Francesco Bistoni; Antonella Mencacci
Journal:  Case Rep Med       Date:  2013-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.